5Suppliers
5Customers
3Debt Items
20Related Chains

Windtree Therapeutics, Inc. Suppliers

TickerNameConfidenceEvidence
VARIAN-BIOPHARMACEUTICALS-INC VARIAN-BIOPHARMACEUTICALS-INC 92% Pursuant to the Asset Purchase Agreement, we purchased all of the assets of Varian’s business associated with a license agreement...
EVFM Evofem Biosciences, Inc. 72% rsuant to the terms of the warrant agreement, the exercise price of the July 2024 Warrants originally issued in connection with the Series C Preferred Stock was reduced to $ effective January 24, 202…
EVFM Evofem Biosciences, Inc. 72% Reciprocal relationship from EVFM graph: Reciprocal relationship from WINT graph: rsuant to the terms of the warrant agreement, the exercise price of the July 2024 Warrants originally issued in conne…
ORANY ORANY 72% Reciprocal relationship from ORANY graph: Reciprocal relationship from WINT graph: Reciprocal relationship from ORANY graph: Reciprocal relationship from WINT graph: Track or Breakthrough Therapy des…
ORANY ORANY 72% Track or Breakthrough Therapy designation or other expedited programs. These designations and programs are intended to facilitate and expedite development and review of a New Drug Application, or NDA…

Windtree Therapeutics, Inc. Customers

TickerNameConfidenceEvidence
EVFM Evofem Biosciences, Inc. 90% we will act as the supplier to Evofem of its Phexxi® product outside of the United States
EVFM Evofem Biosciences, Inc. 90% Reciprocal relationship from EVFM graph: Reciprocal relationship from WINT graph: Reciprocal relationship from EVFM graph: Reciprocal relationship from WINT graph: Reciprocal relationship from EVFM g…
SEVEN-KNOTS-LLC SEVEN-KNOTS-LLC 90% we may sell shares of common stock to Seven Knots from time to time
ORANY ORANY 72% Track or Breakthrough Therapy designation or other expedited programs. These designations and programs are intended to facilitate and expedite development and review of a New Drug Application, or NDA…
ORANY ORANY 72% Reciprocal relationship from ORANY graph: Reciprocal relationship from WINT graph: Track or Breakthrough Therapy designation or other expedited programs. These designations and programs are intended …

Windtree Therapeutics, Inc. Debt Obligations

InstrumentDescriptionConfidenceEvidence
WINT-DEBT-13569 Warrants outstanding: 6 90% xbrl warrant detail from xbrl 2024-12-31.
WINT-DEBT Debt stack $3.5M 90% Market cache reports total debt of $3.5M.
WINT-DEBT-13570 Xbrl Convertible 90% xbrl convertible detail from xbrl 2024-12-31.

Windtree Therapeutics, Inc. Acquisitions

No acquisitions on recordNo completed or pending acquisitions found in our database for Windtree Therapeutics, Inc..

Windtree Therapeutics, Inc. Ownership

No ownership data on recordNo major institutional ownership relationships found in our database for Windtree Therapeutics, Inc..

Windtree Therapeutics, Inc. Extended Supply Chain Network

TickerNameChain IndexHopsRelationship Types
EVFM Evofem Biosciences, Inc. 100.00 1 ['customer', 'supplier']
ORANY ORANGE 100.00 1 ['customer', 'supplier']
AMZE Amaze Holdings, Inc. 50.00 2
CPRX Catalyst Pharmaceuticals, Inc. 50.00 2
AYTU Aytu BioPharma, Inc. 50.00 2
D Dominion Energy, Inc. 50.00 2
CANF Can-Fite BioPharma Ltd. 50.00 2
ESS Essex Property Trust, Inc. 50.00 2
DFTX Definium Therapeutics, Inc. 50.00 2
CHUC Charlie's Holdings, Inc. 50.00 2
CLNE Clean Energy Fuels Corp. 50.00 2
FENC Fennec Pharmaceuticals Inc. 50.00 2
EQR Equity Residential 50.00 2
CNOB ConnectOne Bancorp, Inc. 50.00 2
DWTX Dogwood Therapeutics, Inc. 50.00 2
DARE Daré Bioscience, Inc. 50.00 2
ED Consolidated Edison, Inc. 50.00 2
SCNX Scienture Holdings, Inc. 50.00 2
CORT Corcept Therapeutics Incorporated 50.00 2
CYCN Cyclerion Therapeutics, Inc. 50.00 2